Apply light pressure with a clean cotton ball afterward, but do not rub
As such, GLP-1 RAs and dual GLP/GIP-RAs have emerged as essential drugs for the treatment of patients with type 2 diabetes and, more recently, for the management of weight loss in the absence of diabetes
Tirzepatide is a dual GIP and GLP-1 receptor agonist licensed for type 2 diabetes treatment in the UK Lymphadenopathy is not listed in the Summary of Product Characteristics or reported in SURPASS or SURMOUNT clinical trials Common Mounjaro side effects are predominantly gastrointestinal, including nausea, vomiting, diarrhoea, and reduced appetite Lymph node swelling during treatment may result from infections, vaccinations, local inflammation, or other unrelated conditions Persistent, enlarging, or hard lymph nodes require GP evaluation to exclude serious underlying causes including malignancy Report any suspected adverse effects through the MHRA Yellow Card Scheme for ongoing pharmacovigilance monitoring Table of Contents Understanding Mounjaro and Its Common Side Effects Mounjaro (tirzepatide) is a prescription medication licensed in the UK for the treatment of type 2 diabetes mellitus
Its like once youre in perimenopause, we just only look at that and we dont think about the rest of whats going on
Gradually increase resistance as you gain strength
.webp)
